249 related articles for article (PubMed ID: 35194198)
1. Next generation self-replicating RNA vectors for vaccines and immunotherapies.
Aliahmad P; Miyake-Stoner SJ; Geall AJ; Wang NS
Cancer Gene Ther; 2023 Jun; 30(6):785-793. PubMed ID: 35194198
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials of self-replicating RNA-based cancer vaccines.
Morse MA; Crosby EJ; Force J; Osada T; Hobeika AC; Hartman ZC; Berglund P; Smith J; Lyerly HK
Cancer Gene Ther; 2023 Jun; 30(6):803-811. PubMed ID: 36765179
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
4. Cancer vaccine strategies using self-replicating RNA viral platforms.
Dailey GP; Crosby EJ; Hartman ZC
Cancer Gene Ther; 2023 Jun; 30(6):794-802. PubMed ID: 35821284
[TBL] [Abstract][Full Text] [Related]
5. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
7. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
[TBL] [Abstract][Full Text] [Related]
8. Development of novel SARS-CoV-2 viral vectors.
Liu H; Liu D
Sci Rep; 2023 Aug; 13(1):13053. PubMed ID: 37567900
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
[TBL] [Abstract][Full Text] [Related]
10. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.
Sharma A; Knollmann-Ritschel B
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656
[TBL] [Abstract][Full Text] [Related]
11. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
[TBL] [Abstract][Full Text] [Related]
12. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
Front Immunol; 2020; 11():598847. PubMed ID: 33542715
[TBL] [Abstract][Full Text] [Related]
13. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
[TBL] [Abstract][Full Text] [Related]
14. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
15. Venezuelan Equine Encephalitis Virus Induces Apoptosis through the Unfolded Protein Response Activation of EGR1.
Baer A; Lundberg L; Swales D; Waybright N; Pinkham C; Dinman JD; Jacobs JL; Kehn-Hall K
J Virol; 2016 Jan; 90(7):3558-72. PubMed ID: 26792742
[TBL] [Abstract][Full Text] [Related]
16. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
Phillpotts RJ; Lescott TL; Jacobs SC
Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
[TBL] [Abstract][Full Text] [Related]
18. mRNA vaccines: the most recent clinical applications of synthetic mRNA.
Kwon S; Kwon M; Im S; Lee K; Lee H
Arch Pharm Res; 2022 Apr; 45(4):245-262. PubMed ID: 35426547
[TBL] [Abstract][Full Text] [Related]
19. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
Atasheva S; Kim DY; Frolova EI; Frolov I
J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
[TBL] [Abstract][Full Text] [Related]
20. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers].
Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA
Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
